MENU
GKOS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Glaukos (GKOS) Earnings Date & Reports
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more
Industry: #Medical Specialties
A.I. Advisor
published Earnings
GKOS is expected to report earnings to fall 31.57% to -9 cents per share on October 28
Q3'26
Est.
$-0.10
Q2'26
Beat
by $0.07
Q1'26
Beat
by $0.10
Q4'25
Missed
by $0.69
Q3'25
Beat
by $0.10
The last earnings report on July 29 showed earnings per share of -14 cents, beating the estimate of -20 cents. With 1.03M shares outstanding, the current market capitalization sits at 9.72B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
an ophthalmic medical device company
Industry MedicalNursingServices
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
1094
Web
https://www.glaukos.com